Annual Drug Patent Expirations for ACTONEL
Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and four Paragraph IV challenges.
Drug patent litigation for ACTONEL.
The generic ingredient in ACTONEL is calcium carbonate; risedronate sodium. Two suppliers are listed for this compound. Additional details are available on the calcium carbonate; risedronate sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
